|
|
 |
|
| 2023 ¹2 |
|
Immune Deficiency |
Kastiukevich L.I., Romanova O.N., Kolomiets N.D., Marakhovsky K.Y., Krasko O.V., Nazarenko O.N., Êokareva Ì.V.
Clinical, epidemiological and laboratory characteristics of inflammatory bowel diseases in children with primary immunodeficiency. 
| |
| 2023 ¹2 |
|
ALLERGOLOGY |
Ruban A.P.
Severity assessment for acute allergic reactions.
|
Ravskaya V.V., Paramonova N.S., Khokha R.N.
Allergic rhinitis – a modern outlook.
|
Semernik O.E., Lebedenko A.A., Dobaeva N.M., Spiridenko G.Yu., Klenushkin A.A.
Risk prediction model for severe atopic dermatitis development in children.
|
Kandrashkina Y.A., Orlova E.A., Shtach A.F.
The role of interleukins 31 and 33 in the pathogenesis of atopic dermatitis during pregnancy.
|
Mineev V.N., Vasilieva T.S., Galkina O.V., Trofimov V.I.
Cystatin C levels in bronchial asthma variants.
| |
| 2023 ¹2 |
|
Immunopathology |
Maksimovich A.V., Potapnev M.P., Dunayev I.A., Gushina L.M., Karpenko F.N.
Cytokine profile and anti-inflammatory activity of COVID-19 convalescent plasma in vitro.
|
Aschina L.A., Baranova N.I., Bolgova A.I.
Neutrophil functional activity indices as predictors of COVID-19 severity.
|
Yupatov G.I., Pryshchepenko V.A., Okulich V.K., Denisenko N.V.
Dynamics of liver function indicators in patients with COVID-19.
| |
| 2023 ¹2 |
|
Immunotherapy |
Vasilyeva M.A.
Safety of clinical application of polyvalent intravenous immunoglobulins in pediatrics.
|
|
|
